. . "Blaaskanker"@nl . "Transitional cell carcinoma of the bladder. The white in the bladder is contrast."@en . "\u8180\u80F1\u764C"@ja . . . "Als Blasenkrebs (Blasenkarzinom) werden allgemein von der Harnblase ausgehende b\u00F6sartige Geschw\u00FClste (b\u00F6sartige Tumoren) bezeichnet. Als urs\u00E4chlich f\u00FCr die Entstehung von Blasenkrebs gelten chronische Entz\u00FCndungen (einschlie\u00DFlich Parasiteninfektionen), Tabakkonsum, die Aufnahme bestimmter chemischer Substanzen (beispielsweise aromatische Amine wie 2-Naphthylamin), Strahlenexposition und abwehrunterdr\u00FCckende Medikamente. Behandelt wird der Harnblasenkrebs je nach Ausdehnung mit einer transurethralen Resektion der Harnblase (TUR-B), der kompletten Entfernung der Blase, einer lokalen Chemotherapie oder auch einer Strahlentherapie in Kombination mit einer systemischen Chemotherapie. Die Heilungsaussichten sind bei fr\u00FCh entdecktem Krebsleiden gut, bei bereits ausgedehnter Erkrankung mit Metastasen jedoch gering."@de . . . "549000"^^ . . . "Bladder cancer"@en . . . . . . "D001749"@en . . . . . . . "67.0"^^ . . . . . . "C\u00E0ncer de bufeta urin\u00E0ria"@ca . . . . . . . "486"^^ . . . . . . . "Kanker kandung kemih"@in . . . . "\u8180\u80F1\u764C \u6CDB\u6307\u5404\u7A2E\u51FA\u81EA\u8180\u80F1\u7684\u60E1\u6027\u816B\u7624\uFF0C\u4E5F\u5C31\u662F\u6709\u7570\u5E38\u7D30\u80DE\u5927\u91CF\u589E\u6B96\u800C\u4E0D\u53D7\u7BA1\u5236\u3002\u8180\u80F1\u662F\u8CAF\u5B58\u5C3F\u6DB2\u7684\u4E2D\u7A7A\u5668\u5B98\uFF0C\u5916\u58C1\u4E3B\u8981\u7531\u808C\u8089\u69CB\u6210\uFF0C\u4F4D\u65BC\u4E0B\u8179\u90E8\u3002\u6700\u5E38\u898B\u7684\u8180\u80F1\u764C\u7D30\u80DE\u4F86\u81EA\u8180\u80F1\u5167\u9762\u9ECF\u819C\u8868\u76AE\uFF0C\u6B63\u5F0F\u540D\u7A31\u70BA\u79FB\u884C\u4E0A\u76AE\u7D30\u80DE\u764C(TCC)\u3002 \u7F79\u60A3\u8180\u80F1\u764C\u6700\u4E3B\u8981\u7684\u5371\u96AA\u56E0\u5B50\u662F\u4F86\u81EA\u57FA\u56E0\u7684\u5F71\u97FF\uFF0C\u53E6\u5916\u5438\u83F8\u3001\u9577\u671F\u63A5\u89F8\u67D0\u7A2E\u67D3\u6599\uFF08\u542B\u82EF\u80FA\uFF08aniline\uFF09\u6210\u4EFD\u8005\uFF0C\u5982\u7D21\u7E54\u5EE0\u54E1\u5DE5\u5C31\u53EF\u80FD\u63A5\u89F8\u5230\uFF09\u3001\u6C7D\u6CB9\u6216\u5176\u4ED6\u5316\u5B78\u7269\u8CEA\u8005\u4E5F\u6709\u8F03\u9AD8\u7684\u98A8\u96AA\u3002\u6709\u52D5\u7269\u5BE6\u9A57\u986F\u793A\u8001\u9F20\u9577\u671F\u5927\u91CF\u670D\u7528\u4E00\u7A2E\u4EBA\u5DE5\u751C\u5473\u5242\"\u7CD6\u7CBE\"\uFF08\u6C99\u5361\u6797/saccharin\uFF09\u53EF\u5C0E\u81F4\u8180\u80F1\u764C\uFF0C\u4F46\u4EBA\u9AD4\u5C1A\u672A\u6709\u76F8\u540C\u7684\u5831\u544A\uFF1B\u53E6\u4E00\u7A2E\u66F4\u5E38\u7528\u7684\u4EBA\u5DE5\u751C\u5473\u5291\u963F\u65AF\u5DF4\u751C\uFF08aspartame\uFF09\u5247\u6C92\u6709\u985E\u4F3C\u5831\u544A\u3002"@zh . . . . . . "\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0647\u0648 \u0625\u0635\u0627\u0628\u0629 \u0633\u0631\u0637\u0627\u0646\u064A\u0629 \u0644\u0645\u0646\u0637\u0642\u0629 \u0627\u0644\u0645\u062B\u0627\u0646\u0629. \u064A\u0628\u062F\u0623 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0641\u064A \u0645\u0639\u0638\u0645 \u0627\u0644\u0623\u062D\u064A\u0627\u0646 \u0628\u0625\u0635\u0627\u0628\u0629 \u0627\u0644\u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u0645\u0628\u0637\u0646\u0629 \u0644\u0644\u0645\u062B\u0627\u0646\u0629 \u0645\u0646 \u0627\u0644\u062F\u0627\u062E\u0644. \u0648\u0639\u0627\u062F\u0629 \u0645\u0627 \u064A\u0635\u064A\u0628 \u0643\u0628\u0627\u0631 \u0627\u0644\u0633\u0646\u060C \u0625\u0644\u0627 \u0623\u0646 \u0647\u0630\u0627 \u0644\u0627 \u064A\u0639\u0646\u064A \u0627\u0633\u062A\u062B\u0646\u0627\u0621 \u0623\u064A \u0633\u0646 \u0645\u0646 \u0627\u0644\u0625\u0635\u0627\u0628\u0629. \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0647\u0648 \u0631\u0627\u0628\u0639 \u0623\u0643\u062B\u0631 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u0627\u062A \u0634\u064A\u0648\u0639\u0627 \u0628\u064A\u0646 \u0627\u0644\u0631\u062C\u0627\u0644 \u0648\u0627\u0644\u062B\u0627\u0645\u0646 \u0627\u0644\u0623\u0643\u062B\u0631 \u0634\u064A\u0648\u0639\u0627 \u0644\u062F\u0649 \u0627\u0644\u0646\u0633\u0627\u0621 \u062D\u0633\u0628 \u0627\u0644\u0623\u0645\u0631\u064A\u0643\u064A\u060C \u0648\u064A\u0634\u0643\u0644 \u0631\u0627\u0628\u0639 \u0623\u0643\u062B\u0631 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u0627\u062A \u0634\u064A\u0648\u0639\u0627 \u0628\u064A\u0646 \u0627\u0644\u0631\u062C\u0627\u0644 \u0641\u064A \u0628\u0631\u064A\u0637\u0627\u0646\u064A\u0627. \u0641\u064A \u0639\u0627\u0645 1996 \u0623\u0643\u062B\u0631 \u0645\u0646 300000 \u062D\u0627\u0644\u0629 \u062C\u062F\u064A\u062F\u0629 \u062A\u0645 \u062A\u0634\u062E\u064A\u0635\u0647\u0627 \u0641\u064A \u062C\u0645\u064A\u0639 \u0623\u0646\u062D\u0627\u0621 \u0627\u0644\u0639\u0627\u0644\u0645. \u064A\u062A\u0645 \u062A\u0634\u062E\u064A\u0635 \u0627\u0644\u063A\u0627\u0644\u0628\u064A\u0629 \u0627\u0644\u0639\u0638\u0645\u0649 \u0645\u0646 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0641\u064A \u0645\u0631\u0627\u062D\u0644\u0647 \u0627\u0644\u0645\u0628\u0643\u0631\u0629\u060C \u062D\u064A\u062B \u064A\u0643\u0648\u0646 \u0642\u0627\u0628\u0644\u0627 \u0644\u0644\u0639\u0644\u0627\u062C \u0628\u0635\u0648\u0631\u0629 \u062C\u064A\u062F\u0629 \u062C\u062F\u0627. \u0648\u0644\u0643\u0646\u060C \u0625\u0635\u0627\u0628\u0629 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u062A\u062A\u0645\u064A\u0632 \u0628\u0627\u0644\u062A\u0643\u0631\u0631 \u062D\u062A\u0649 \u0644\u0648 \u062A\u0645 \u0627\u0644\u0639\u0644\u0627\u062C \u0636\u0645\u0646 \u0645\u0631\u062D\u0644\u0629 \u0645\u0628\u0643\u0631\u0629\u060C \u0648\u0644\u0647\u0630\u0627 \u0627\u0644\u0633\u0628\u0628\u060C \u064A\u062A\u0648\u062C\u0628 \u0639\u0644\u0649 \u0627\u0644\u0646\u0627\u062C\u064A\u0646 \u0645\u0646 \u0645\u0631\u0636 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0623\u0646 \u064A\u062A\u0627\u0628\u0639\u0648\u0627 \u0627\u0644\u0627\u062E\u062A\u0628\u0627\u0631\u0627\u062A \u0648\u0645\u0631\u0627\u0642\u0628\u0629 \u062D\u0627\u0644\u062A\u0647\u0645 \u0644\u0639\u062F\u0629 \u0633\u0646\u0648\u0627\u062A \u0628\u0639\u062F \u0627\u0644\u0639\u0644\u0627\u062C. \u0642\u062F\u0631\u062A \u0639\u062F\u062F \u0627\u0644\u0627\u0635\u0627\u0628\u0627\u062A \u0627\u0644\u062C\u062F\u064A\u062F\u0629 \u0628\u0647\u0630\u0627 \u0627\u0644\u0645\u0631\u0636 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0644\u0639\u0627\u0645 2008 \u0628\u062D\u0648\u0627\u0644\u064A 68810 "@ar . "Surgery, radiation therapy, chemotherapy, immunotherapy"@en . . . . . . . . . "C\u00E1ncer de vejiga"@es . . . . . . "\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0647\u0648 \u0625\u0635\u0627\u0628\u0629 \u0633\u0631\u0637\u0627\u0646\u064A\u0629 \u0644\u0645\u0646\u0637\u0642\u0629 \u0627\u0644\u0645\u062B\u0627\u0646\u0629. \u064A\u0628\u062F\u0623 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0641\u064A \u0645\u0639\u0638\u0645 \u0627\u0644\u0623\u062D\u064A\u0627\u0646 \u0628\u0625\u0635\u0627\u0628\u0629 \u0627\u0644\u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u0645\u0628\u0637\u0646\u0629 \u0644\u0644\u0645\u062B\u0627\u0646\u0629 \u0645\u0646 \u0627\u0644\u062F\u0627\u062E\u0644. \u0648\u0639\u0627\u062F\u0629 \u0645\u0627 \u064A\u0635\u064A\u0628 \u0643\u0628\u0627\u0631 \u0627\u0644\u0633\u0646\u060C \u0625\u0644\u0627 \u0623\u0646 \u0647\u0630\u0627 \u0644\u0627 \u064A\u0639\u0646\u064A \u0627\u0633\u062A\u062B\u0646\u0627\u0621 \u0623\u064A \u0633\u0646 \u0645\u0646 \u0627\u0644\u0625\u0635\u0627\u0628\u0629. \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0647\u0648 \u0631\u0627\u0628\u0639 \u0623\u0643\u062B\u0631 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u0627\u062A \u0634\u064A\u0648\u0639\u0627 \u0628\u064A\u0646 \u0627\u0644\u0631\u062C\u0627\u0644 \u0648\u0627\u0644\u062B\u0627\u0645\u0646 \u0627\u0644\u0623\u0643\u062B\u0631 \u0634\u064A\u0648\u0639\u0627 \u0644\u062F\u0649 \u0627\u0644\u0646\u0633\u0627\u0621 \u062D\u0633\u0628 \u0627\u0644\u0623\u0645\u0631\u064A\u0643\u064A\u060C \u0648\u064A\u0634\u0643\u0644 \u0631\u0627\u0628\u0639 \u0623\u0643\u062B\u0631 \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u0627\u062A \u0634\u064A\u0648\u0639\u0627 \u0628\u064A\u0646 \u0627\u0644\u0631\u062C\u0627\u0644 \u0641\u064A \u0628\u0631\u064A\u0637\u0627\u0646\u064A\u0627. \u0641\u064A \u0639\u0627\u0645 1996 \u0623\u0643\u062B\u0631 \u0645\u0646 300000 \u062D\u0627\u0644\u0629 \u062C\u062F\u064A\u062F\u0629 \u062A\u0645 \u062A\u0634\u062E\u064A\u0635\u0647\u0627 \u0641\u064A \u062C\u0645\u064A\u0639 \u0623\u0646\u062D\u0627\u0621 \u0627\u0644\u0639\u0627\u0644\u0645. \u064A\u062A\u0645 \u062A\u0634\u062E\u064A\u0635 \u0627\u0644\u063A\u0627\u0644\u0628\u064A\u0629 \u0627\u0644\u0639\u0638\u0645\u0649 \u0645\u0646 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0641\u064A \u0645\u0631\u0627\u062D\u0644\u0647 \u0627\u0644\u0645\u0628\u0643\u0631\u0629\u060C \u062D\u064A\u062B \u064A\u0643\u0648\u0646 \u0642\u0627\u0628\u0644\u0627 \u0644\u0644\u0639\u0644\u0627\u062C \u0628\u0635\u0648\u0631\u0629 \u062C\u064A\u062F\u0629 \u062C\u062F\u0627. \u0648\u0644\u0643\u0646\u060C \u0625\u0635\u0627\u0628\u0629 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u062A\u062A\u0645\u064A\u0632 \u0628\u0627\u0644\u062A\u0643\u0631\u0631 \u062D\u062A\u0649 \u0644\u0648 \u062A\u0645 \u0627\u0644\u0639\u0644\u0627\u062C \u0636\u0645\u0646 \u0645\u0631\u062D\u0644\u0629 \u0645\u0628\u0643\u0631\u0629\u060C \u0648\u0644\u0647\u0630\u0627 \u0627\u0644\u0633\u0628\u0628\u060C \u064A\u062A\u0648\u062C\u0628 \u0639\u0644\u0649 \u0627\u0644\u0646\u0627\u062C\u064A\u0646 \u0645\u0646 \u0645\u0631\u0636 \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629 \u0623\u0646 \u064A\u062A\u0627\u0628\u0639\u0648\u0627 \u0627\u0644\u0627\u062E\u062A\u0628\u0627\u0631\u0627\u062A \u0648\u0645\u0631\u0627\u0642\u0628\u0629 \u062D\u0627\u0644\u062A\u0647\u0645 \u0644\u0639\u062F\u0629 \u0633\u0646\u0648\u0627\u062A \u0628\u0639\u062F \u0627\u0644\u0639\u0644\u0627\u062C. \u0642\u062F\u0631\u062A \u0639\u062F\u062F \u0627\u0644\u0627\u0635\u0627\u0628\u0627\u062A \u0627\u0644\u062C\u062F\u064A\u062F\u0629 \u0628\u0647\u0630\u0627 \u0627\u0644\u0645\u0631\u0636 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0644\u0639\u0627\u0645 2008 \u0628\u062D\u0648\u0627\u0644\u064A 68810 \u0625\u0635\u0627\u0628\u0629\u060C \u0643\u0627\u0646 \u0639\u062F\u062F \u0627\u0644\u0648\u0641\u064A\u0627\u062A \u0636\u0645\u0646\u0647\u0627 14000 \u062D\u0627\u0644\u0629."@ar . . "C\u00E2ncer de bexiga"@pt . "\u0420\u0430\u043A \u0441\u0435\u0447\u043E\u0432\u043E\u0433\u043E \u043C\u0456\u0445\u0443\u0440\u0430"@uk . . . . . "Urinv\u00E4gscancer \u00E4r cancer som utg\u00E5r fr\u00E5n urinv\u00E4garna, det vill s\u00E4ga i urinbl\u00E5sa, urinledare eller urinr\u00F6r. Cancerformen \u00E4r vanligare i v\u00E4stv\u00E4rlden \u00E4n s\u00F6der om Egypten, i vilket land den \u00E4r som vanligast. De flesta som drabbas \u00E4r m\u00E4n, och i synnerhet \u00E4ldre personer. Urinv\u00E4gscancer \u00E4r vanligen av formen , skivepitelcancer, eller adenocarcinom, vilka samtliga \u00E4r olika slags carcinom. Symtom p\u00E5 urinv\u00E4gscancer \u00E4r blod i urinen (hematuri), polyuri, ryggsm\u00E4rta, och nedre magsm\u00E4rta. Urinbl\u00E5san och urinv\u00E4garna m\u00E5ste unders\u00F6kas med cystoskop och biopsi ska tas, dessutom b\u00F6r datortomografi g\u00F6ras."@sv . . . . "Urinv\u00E4gscancer"@sv . . . . "Bladder cancer"@en . . . . "Rak p\u0119cherza moczowego (ang. bladder cancer) \u2013 pierwotny nowotw\u00F3r z\u0142o\u015Bliwy p\u0119cherza moczowego pochodzenia nab\u0142onkowego. Histologicznie u ludzi zdecydowan\u0105 wi\u0119kszo\u015B\u0107 rak\u00F3w p\u0119cherza moczowego stanowi rak urotelialny (z kom\u00F3rek nab\u0142onka dr\u00F3g moczowych), nazywany r\u00F3wnie\u017C rakiem przej\u015Bciowokom\u00F3rkowym. Nowotw\u00F3r jest chorob\u0105 niejednorodn\u0105 i stanowi spektrum zmian o zr\u00F3\u017Cnicowanym stopniu z\u0142o\u015Bliwo\u015Bci, g\u0142\u0119boko\u015Bci naciekania oraz ryzyka progresji choroby. Najwa\u017Cniejszym czynnikiem ryzyka rozwoju raka p\u0119cherza moczowego jest palenie tytoniu. Najcz\u0119stszym objawem choroby jest bezbolesny, okresowy krwiomocz."@pl . . . "188" . . "Kanker kandung kemih adalah sebuah jenis kanker yang timbul dari jaringan kandung kemih. Kanker kandung kemih sering kali ditandai dengan adanya darah dalam urin. Kanker kandung kemih terjadi ketika sel-sel di dalam kandung kemih tumbuh tidak terkendali dan membentuk sel kanker. Jika terus tumbuh, sel kanker bisa menyebar ke jaringan di sekitar kandung kemih, atau menyebar ke organ lain yang lebih jauh, seperti hati, tulang, dan paru-paru."@in . "\u8180\u80F1\u764C\uFF08\u307C\u3046\u3053\u3046\u304C\u3093\u3001\u82F1: Bladder cancer\uFF09\u306F\u3001\u8180\u80F1\u304B\u3089\u767A\u751F\u3059\u308B\u4E0A\u76AE\u6027\u60AA\u6027\u816B\u760D\u3067\u3042\u308B\u3002"@ja . . . "Con la locuzione carcinoma della vescica si fa riferimento ad una categoria diagnostica che comprende l'insieme delle neoplasie maligne che originano dal tessuto epiteliale (carcinomi) che compone la vescica urinaria. Nell'accezione comune, il termine carcinoma viene sovente ad essere sostituito con il termine pi\u00F9 generico di cancro o tumore in quanto neoplasie di origine diversa (sarcomi, melanomi, linfomi) costituiscono un'entit\u00E0 patologica molto rara per la vescica."@it . . . . . . . . . . . . . . . "\uBC29\uAD11\uC554(\u8180\u80F1\u764C)\uC740 \uBC29\uAD11\uC5D0\uC11C \uBC1C\uC0DD\uD558\uB294 \uC0C1\uD53C \uC545\uC131 \uC885\uC591\uC774\uB2E4. \uC99D\uC0C1\uC73C\uB85C \uD608\uB1E8 \uB4F1\uC774 \uBC1C\uC0DD\uD55C\uB2E4. \uD761\uC5F0\uC774 \uC8FC\uC694 \uC6D0\uC778\uC73C\uB85C \uBCF4\uC778\uB2E4. \uD45C\uC7AC\uC131 \uC885\uC591\uC758 \uCD5C\uC18C\uD55C\uC758 \uCE58\uB8CC\uB294 \uB0B4\uC2DC\uACBD\uC801 \uC644\uC804\uC808\uC81C\uC774\uB2E4. \uADFC\uC721\uCDA9\uC744 \uCCA8\uBC94\uD558\uB294 \uC9C8\uD658\uC758 \uACBD\uC6B0\uB294 \uC6D0\uBC1C\uC554\uC758 \uCE58\uB8CC\uC640 \uBBF8\uC138\uC804\uC774\uC554 \uCE58\uB8CC\uB97C \uC704\uD55C \uC804\uC2E0 \uD56D\uC554\uC694\uBC95\uC73C\uB85C \uB098\uB260 \uC218 \uC788\uB2E4. \uB610\uD55C \uAC15\uC544\uC9C0\uC5D0\uAC8C\uB3C4 \uAC78\uB9AC\uAE30\uAC00 \uC26C\uC6B4 \uCE58\uBA85\uC801\uC778 \uC9C8\uBCD1 \uC911\uC758 \uD558\uB098\uC774\uB2E4. \uAC15\uC544\uC9C0 \uBC29\uAD11\uC554\uB3C4 \uC0C1\uC220\uD55C \uBC14\uC640 \uAC19\uC774 \uAC04\uC811 \uD761\uC5F0, \uC0B4\uCDA9\uC81C, \uC81C\uCD08\uC81C \uB4F1\uB3C4 \uBC29\uAD11\uC554\uC744 \uC77C\uC73C\uD0A4\uB294 \uC774\uC720 \uC5ED\uC2DC \uB420 \uC218\uB3C4 \uC788\uB2E4."@ko . . "192762"^^ . . . . . . . . . . . "Rak p\u0119cherza moczowego (ang. bladder cancer) \u2013 pierwotny nowotw\u00F3r z\u0142o\u015Bliwy p\u0119cherza moczowego pochodzenia nab\u0142onkowego. Histologicznie u ludzi zdecydowan\u0105 wi\u0119kszo\u015B\u0107 rak\u00F3w p\u0119cherza moczowego stanowi rak urotelialny (z kom\u00F3rek nab\u0142onka dr\u00F3g moczowych), nazywany r\u00F3wnie\u017C rakiem przej\u015Bciowokom\u00F3rkowym. Nowotw\u00F3r jest chorob\u0105 niejednorodn\u0105 i stanowi spektrum zmian o zr\u00F3\u017Cnicowanym stopniu z\u0142o\u015Bliwo\u015Bci, g\u0142\u0119boko\u015Bci naciekania oraz ryzyka progresji choroby. Najwa\u017Cniejszym czynnikiem ryzyka rozwoju raka p\u0119cherza moczowego jest palenie tytoniu. Najcz\u0119stszym objawem choroby jest bezbolesny, okresowy krwiomocz. Rozpoznanie jest stawiane na podstawie badania histopatologicznego materia\u0142u pobranego podczas cystoskopii z wykonaniem (TURBT). Strategia leczenia raka p\u0119cherza moczowego jest oparta o ocen\u0119 g\u0142\u0119boko\u015Bci naciekania oraz ryzyka nawrotu raka. U cz\u0119\u015Bci chorych wystarczaj\u0105cym leczeniem jest przezcewkowa elektroresekcja, ale cz\u0119\u015B\u0107 chorych wymaga chemioterapii dop\u0119cherzowej albo dop\u0119cherzowej immunoterapii BCG. U chorych z naciekaniem mi\u0119\u015Bni\u00F3wki oraz chorych z rakiem o najwy\u017Cszym ryzyku nawrotu albo nawrotem opornym na leczenie BCG konieczne jest chirurgiczne wyci\u0119cie p\u0119cherza nazywane . Cystektomi\u0119 u chorych z rakiem naciekaj\u0105cym mi\u0119\u015Bni\u00F3wk\u0119 poprzedza chemioterapia neoadiuwantowa. Leczenie choroby z przerzutami jest oparte o chemioterapi\u0119 z u\u017Cyciem program\u00F3w zawieraj\u0105cych cisplatyn\u0119."@pl . . . . . . . . . . . . "1122677418"^^ . . . . . . . . . "711"@en . . . . "La paroi interne de la vessie est tapiss\u00E9e de cellules transitionnelles qui sont \u00E0 l'origine de la plupart des cancers de la vessie.L'\u00E9volution et la prise en charge d\u00E9pend beaucoup du caract\u00E8re invasif de la tumeur. On distingue le cancer superficiel de la vessie du cancer invasif (tumeur infiltrante). Si le cancer superficiel reste de bon pronostic, le cancer invasif de la vessie est beaucoup plus grave et n\u00E9cessite des traitements agressifs."@fr . "La paroi interne de la vessie est tapiss\u00E9e de cellules transitionnelles qui sont \u00E0 l'origine de la plupart des cancers de la vessie.L'\u00E9volution et la prise en charge d\u00E9pend beaucoup du caract\u00E8re invasif de la tumeur. On distingue le cancer superficiel de la vessie du cancer invasif (tumeur infiltrante). Si le cancer superficiel reste de bon pronostic, le cancer invasif de la vessie est beaucoup plus grave et n\u00E9cessite des traitements agressifs."@fr . . "\u8180\u80F1\u764C"@zh . "D001749" . . "Als Blasenkrebs (Blasenkarzinom) werden allgemein von der Harnblase ausgehende b\u00F6sartige Geschw\u00FClste (b\u00F6sartige Tumoren) bezeichnet. Als urs\u00E4chlich f\u00FCr die Entstehung von Blasenkrebs gelten chronische Entz\u00FCndungen (einschlie\u00DFlich Parasiteninfektionen), Tabakkonsum, die Aufnahme bestimmter chemischer Substanzen (beispielsweise aromatische Amine wie 2-Naphthylamin), Strahlenexposition und abwehrunterdr\u00FCckende Medikamente. Behandelt wird der Harnblasenkrebs je nach Ausdehnung mit einer transurethralen Resektion der Harnblase (TUR-B), der kompletten Entfernung der Blase, einer lokalen Chemotherapie oder auch einer Strahlentherapie in Kombination mit einer systemischen Chemotherapie. Die Heilungsaussichten sind bei fr\u00FCh entdecktem Krebsleiden gut, bei bereits ausgedehnter Erkrankung mit Metasta"@de . . "Onder blaaskanker of blaascarcinoom wordt een kwaadaardige woekering van de epitheelcellen van het urineblaasslijmvlies verstaan."@nl . . . "188"^^ . . . . . . . . . . . . "Rak p\u0119cherza moczowego"@pl . . . . . . . . "El c\u00E1ncer de vejiga o c\u00E1ncer vesical es un tipo de tumor maligno que aparece en la vejiga urinaria. Los principales factores para el desarrollo del c\u00E1ncer de vejiga incluyen productos qu\u00EDmicos espec\u00EDficos, que se encuentran fundamentalmente en el humo de los cigarrillos. En los pa\u00EDses del Tercer Mundo, ciertas infecciones parasitarias. El tratamiento del c\u00E1ncer vesical gira en funci\u00F3n de la extensi\u00F3n del mismo, generalmente se resuelve con quimioterapia, la remoci\u00F3n de la vejiga o la quimioterapia sist\u00E9mica. Se distinguen el c\u00E1ncer superficial de vejiga del c\u00E1ncer invasivo. Si el c\u00E1ncer sigue siendo superficial, suele cursar con un buen pron\u00F3stico, mientras que el c\u00E1ncer invasivo de la vejiga es mucho m\u00E1s grave y requiere tratamiento agresivo. Cuando la enfermedad se asocia con la amplia presencia de met\u00E1stasis ya no es posible la curaci\u00F3n del paciente. El interior de la vejiga est\u00E1 revestido con las c\u00E9lulas de transici\u00F3n que son responsables de la mayor\u00EDa de los c\u00E1nceres de la vejiga. La progresi\u00F3n depende en gran medida de la agresividad del tumor. La edad avanzada y las enfermedades coexistentes se asocian a tasas m\u00E1s altas de mortalidad por cualquier causa.\u200B"@es . . . . "\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u062B\u0627\u0646\u0629"@ar . . . . . . . . . . . . . "Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. Symptoms include blood in the urine, pain with urination, and low back pain. It is caused when epithelial cells that line the bladder become malignant."@en . "radio"@en . . . . . . . . "\u8180\u80F1\u764C\uFF08\u307C\u3046\u3053\u3046\u304C\u3093\u3001\u82F1: Bladder cancer\uFF09\u306F\u3001\u8180\u80F1\u304B\u3089\u767A\u751F\u3059\u308B\u4E0A\u76AE\u6027\u60AA\u6027\u816B\u760D\u3067\u3042\u308B\u3002"@ja . . . . . . . . . . . . . . "Con la locuzione carcinoma della vescica si fa riferimento ad una categoria diagnostica che comprende l'insieme delle neoplasie maligne che originano dal tessuto epiteliale (carcinomi) che compone la vescica urinaria. Nell'accezione comune, il termine carcinoma viene sovente ad essere sostituito con il termine pi\u00F9 generico di cancro o tumore in quanto neoplasie di origine diversa (sarcomi, melanomi, linfomi) costituiscono un'entit\u00E0 patologica molto rara per la vescica."@it . "1427"^^ . . . . . . . "1427" . . . . . . "200000"^^ . . . . . . . . . . . . . . . . . "Urinv\u00E4gscancer \u00E4r cancer som utg\u00E5r fr\u00E5n urinv\u00E4garna, det vill s\u00E4ga i urinbl\u00E5sa, urinledare eller urinr\u00F6r. Cancerformen \u00E4r vanligare i v\u00E4stv\u00E4rlden \u00E4n s\u00F6der om Egypten, i vilket land den \u00E4r som vanligast. De flesta som drabbas \u00E4r m\u00E4n, och i synnerhet \u00E4ldre personer. Urinv\u00E4gscancer \u00E4r vanligen av formen , skivepitelcancer, eller adenocarcinom, vilka samtliga \u00E4r olika slags carcinom. Symtom p\u00E5 urinv\u00E4gscancer \u00E4r blod i urinen (hematuri), polyuri, ryggsm\u00E4rta, och nedre magsm\u00E4rta. Riskfaktorer \u00E4r h\u00F6g \u00E5lder, r\u00F6kning, att uts\u00E4ttas f\u00F6r cancerframkallande \u00E4mnen, tidigare genomg\u00E5ngen cancerbehandling, och att vara \u00E4rftligt predisponerad f\u00F6r cancer. Sn\u00E4ckfeber (schistosomiasis, bilharzios) som \u00E4r l\u00E5ngt g\u00E5ngen kan orsaka urinbl\u00E5secancer. Infektionssjukdomen sn\u00E4ckfeber f\u00F6rekommer framf\u00F6r allt i tropiska och subtropsiska l\u00E4nder, och urinbl\u00E5secancer \u00E4r den vanligaste cancerformen i Egypten och vissa andra l\u00E4nder i Afrika samt vissa l\u00E4nder i Mellan\u00F6stern vilket har kopplats till sn\u00E4ckfeber. Urinbl\u00E5san och urinv\u00E4garna m\u00E5ste unders\u00F6kas med cystoskop och biopsi ska tas, dessutom b\u00F6r datortomografi g\u00F6ras. Behandling \u00E4r antingen kirurgi eller cellgifter."@sv . . "135447"^^ . . . . . . . "\u0420\u0430\u043A \u043C\u043E\u0447\u0435\u0432\u043E\u0301\u0433\u043E \u043F\u0443\u0437\u044B\u0440\u044F\u0301 (\u0420\u041C\u041F) \u2014 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0435, \u043F\u0440\u0438 \u043A\u043E\u0442\u043E\u0440\u043E\u043C \u0432 \u0441\u043B\u0438\u0437\u0438\u0441\u0442\u043E\u0439 \u043E\u0431\u043E\u043B\u043E\u0447\u043A\u0435 \u0438\u043B\u0438 \u0432 \u0441\u0442\u0435\u043D\u043A\u0435 \u043C\u043E\u0447\u0435\u0432\u043E\u0433\u043E \u043F\u0443\u0437\u044B\u0440\u044F \u0432\u043E\u0437\u043D\u0438\u043A\u0430\u044E\u0442 \u0437\u043B\u043E\u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043D\u043D\u044B\u0435 \u043D\u043E\u0432\u043E\u043E\u0431\u0440\u0430\u0437\u043E\u0432\u0430\u043D\u0438\u044F."@ru . . . "El c\u00E0ncer de bufeta urin\u00E0ria (o, senzillament, c\u00E0ncer de bufeta) fa refer\u00E8ncia a qualsevol dels diversos tipus de tumors malignes de la bufeta urin\u00E0ria. El tipus m\u00E9s com\u00FA de c\u00E0ncer de bufeta comen\u00E7a en les c\u00E8l\u00B7lules que recobreixen l'interior (l'uroteli) de la bufeta i es diu . Els principals factors per al desenvolupament del c\u00E0ncer de bufeta inclouen productes qu\u00EDmics espec\u00EDfics, que es troben fonamentalment en el fum dels cigarrets. Als pa\u00EFsos del Tercer M\u00F3n, certes infeccions parasit\u00E0ries. Es distingeixen el c\u00E0ncer superficial de bufeta del c\u00E0ncer invasiu. Si el c\u00E0ncer continua sent superficial, sol cursar amb un bon pron\u00F2stic, mentre que el c\u00E0ncer invasiu de la bufeta \u00E9s molt m\u00E9s greu i requereix tractament agressiu. El tractament del c\u00E0ncer vesical gira en funci\u00F3 de la seva extensi\u00F3,"@ca . . . . . . . "Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. Symptoms include blood in the urine, pain with urination, and low back pain. It is caused when epithelial cells that line the bladder become malignant. Risk factors for bladder cancer include smoking, family history, prior radiation therapy, frequent bladder infections, and exposure to certain chemicals. The most common type is transitional cell carcinoma. Other types include squamous cell carcinoma and adenocarcinoma. Diagnosis is typically by cystoscopy with tissue biopsies. Staging of the cancer is determined by transurethral resection and medical imaging. Treatment depends on the stage of the cancer. It may include some combination of surgery, radiation therapy, chemotherapy, or immunotherapy. Surgical options may include transurethral resection, partial or complete removal of the bladder, or urinary diversion. The typical five-year survival rates in the United States is 77%, Canada is 75%, and Europe is 68%. Bladder cancer, as of 2018, affected about 1.6 million people globally with 549,000 new cases and 200,000 deaths. Age of onset is most often between 65 and 84 years of age. Males are more often affected than females. In 2018, the highest rate of bladder cancer occurred in Southern and Western Europe followed by North America with rates of 15, 13, and 12 cases per 100,000 people. The highest rates of bladder cancer deaths were seen in Northern Africa and Western Asia followed by Southern Europe."@en . . . . . . . . . . . "Five-year survival rates ~77%"@en . . . . . . . . . . . . "C67" . . . . . . . . . . . . . . "\u0420\u0430\u043A \u043C\u043E\u0447\u0435\u0432\u043E\u0301\u0433\u043E \u043F\u0443\u0437\u044B\u0440\u044F\u0301 (\u0420\u041C\u041F) \u2014 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0435, \u043F\u0440\u0438 \u043A\u043E\u0442\u043E\u0440\u043E\u043C \u0432 \u0441\u043B\u0438\u0437\u0438\u0441\u0442\u043E\u0439 \u043E\u0431\u043E\u043B\u043E\u0447\u043A\u0435 \u0438\u043B\u0438 \u0432 \u0441\u0442\u0435\u043D\u043A\u0435 \u043C\u043E\u0447\u0435\u0432\u043E\u0433\u043E \u043F\u0443\u0437\u044B\u0440\u044F \u0432\u043E\u0437\u043D\u0438\u043A\u0430\u044E\u0442 \u0437\u043B\u043E\u043A\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043D\u043D\u044B\u0435 \u043D\u043E\u0432\u043E\u043E\u0431\u0440\u0430\u0437\u043E\u0432\u0430\u043D\u0438\u044F."@ru . . . . . . . . . . . . "Carcinoma della vescica"@it . . . . "Smoking, family history, prior radiation therapy, frequent bladder infections, certain chemicals"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Bladder cancer"@en . . . "radio"@en . "\uBC29\uAD11\uC554"@ko . . . . . . "711"^^ . . "109800"^^ . . . . "C\u00E2ncer de bexiga (portugu\u00EAs brasileiro) ou cancro da bexiga (portugu\u00EAs europeu) (tamb\u00E9m chamado de Carcinoma Urotelial) \u00E9 um dos v\u00E1rios tipos de c\u00E2ncer, decorrentes de tecidos da bexiga urin\u00E1ria, no qual as c\u00E9lulas da doen\u00E7a crescem de forma anormal e t\u00EAm o potencial de se espalhar para outras partes do corpo. Sintomas incluem sangue na urina, dor ao urinar e dor lombar. Os fatores de risco para o c\u00E2ncer de bexiga incluem o tabagismo, hist\u00F3rico familiar, antes da terapia de radia\u00E7\u00E3o, infec\u00E7\u00F5es da bexiga frequentes, e a exposi\u00E7\u00E3o a determinados produtos qu\u00EDmicos. O tipo mais comum \u00E9 o . Outros tipos incluem o carcinoma de c\u00E9lulas escamosas e adenocarcinoma. O diagn\u00F3stico normalmente realizado pela cistoscopia com bi\u00F3psias de tecido. O est\u00E1gio do c\u00E2ncer normalmente \u00E9 determinado pelo imagiologia m\u00E9dica, tais como tomografia computadorizada e cintilografia \u00F3ssea. O tratamento depende do est\u00E1gio do c\u00E2ncer e pode incluir uma combina\u00E7\u00E3o de cirurgia, radioterapia, quimioterapia ou imunoterapia. Op\u00E7\u00F5es cir\u00FArgicas podem incluir a ressec\u00E7\u00E3o transuretral, remo\u00E7\u00E3o parcial ou completa da bexiga ou desvio urin\u00E1rio. A taxa de sobreviv\u00EAncia de 5 anos, nos Estados Unidos, s\u00E3o de 77%. O c\u00E2ncer de bexiga, em 2015, afetou cerca de 3,4 milh\u00F5es de pessoas com 430.000 novos casos por ano. A idade de in\u00EDcio \u00E9 mais frequentemente entre 65 e 85 anos de idade e os homens s\u00E3o mais freq\u00FCentemente afetados que as mulheres. Em 2015, resultou em 188.000 mortes."@pt . . . . . . ""@en . . . . . . . . . "Kanker kandung kemih adalah sebuah jenis kanker yang timbul dari jaringan kandung kemih. Kanker kandung kemih sering kali ditandai dengan adanya darah dalam urin. Kanker kandung kemih terjadi ketika sel-sel di dalam kandung kemih tumbuh tidak terkendali dan membentuk sel kanker. Jika terus tumbuh, sel kanker bisa menyebar ke jaringan di sekitar kandung kemih, atau menyebar ke organ lain yang lebih jauh, seperti hati, tulang, dan paru-paru."@in . . . . "000486" . . . . . . "\u0420\u0430\u043A \u043C\u043E\u0447\u0435\u0432\u043E\u0433\u043E \u043F\u0443\u0437\u044B\u0440\u044F"@ru . . . . . . . . . . . . . "Cancer de la vessie"@fr . . . . . . . "Onder blaaskanker of blaascarcinoom wordt een kwaadaardige woekering van de epitheelcellen van het urineblaasslijmvlies verstaan."@nl . . "2.6508384E9"^^ . . . . . . . "\u8180\u80F1\u764C \u6CDB\u6307\u5404\u7A2E\u51FA\u81EA\u8180\u80F1\u7684\u60E1\u6027\u816B\u7624\uFF0C\u4E5F\u5C31\u662F\u6709\u7570\u5E38\u7D30\u80DE\u5927\u91CF\u589E\u6B96\u800C\u4E0D\u53D7\u7BA1\u5236\u3002\u8180\u80F1\u662F\u8CAF\u5B58\u5C3F\u6DB2\u7684\u4E2D\u7A7A\u5668\u5B98\uFF0C\u5916\u58C1\u4E3B\u8981\u7531\u808C\u8089\u69CB\u6210\uFF0C\u4F4D\u65BC\u4E0B\u8179\u90E8\u3002\u6700\u5E38\u898B\u7684\u8180\u80F1\u764C\u7D30\u80DE\u4F86\u81EA\u8180\u80F1\u5167\u9762\u9ECF\u819C\u8868\u76AE\uFF0C\u6B63\u5F0F\u540D\u7A31\u70BA\u79FB\u884C\u4E0A\u76AE\u7D30\u80DE\u764C(TCC)\u3002 \u7F79\u60A3\u8180\u80F1\u764C\u6700\u4E3B\u8981\u7684\u5371\u96AA\u56E0\u5B50\u662F\u4F86\u81EA\u57FA\u56E0\u7684\u5F71\u97FF\uFF0C\u53E6\u5916\u5438\u83F8\u3001\u9577\u671F\u63A5\u89F8\u67D0\u7A2E\u67D3\u6599\uFF08\u542B\u82EF\u80FA\uFF08aniline\uFF09\u6210\u4EFD\u8005\uFF0C\u5982\u7D21\u7E54\u5EE0\u54E1\u5DE5\u5C31\u53EF\u80FD\u63A5\u89F8\u5230\uFF09\u3001\u6C7D\u6CB9\u6216\u5176\u4ED6\u5316\u5B78\u7269\u8CEA\u8005\u4E5F\u6709\u8F03\u9AD8\u7684\u98A8\u96AA\u3002\u6709\u52D5\u7269\u5BE6\u9A57\u986F\u793A\u8001\u9F20\u9577\u671F\u5927\u91CF\u670D\u7528\u4E00\u7A2E\u4EBA\u5DE5\u751C\u5473\u5242\"\u7CD6\u7CBE\"\uFF08\u6C99\u5361\u6797/saccharin\uFF09\u53EF\u5C0E\u81F4\u8180\u80F1\u764C\uFF0C\u4F46\u4EBA\u9AD4\u5C1A\u672A\u6709\u76F8\u540C\u7684\u5831\u544A\uFF1B\u53E6\u4E00\u7A2E\u66F4\u5E38\u7528\u7684\u4EBA\u5DE5\u751C\u5473\u5291\u963F\u65AF\u5DF4\u751C\uFF08aspartame\uFF09\u5247\u6C92\u6709\u985E\u4F3C\u5831\u544A\u3002"@zh . "Blasenkrebs"@de . . "Cystoscopy with tissue biopsies"@en . . . . . . . . . . . . . . . . "El c\u00E0ncer de bufeta urin\u00E0ria (o, senzillament, c\u00E0ncer de bufeta) fa refer\u00E8ncia a qualsevol dels diversos tipus de tumors malignes de la bufeta urin\u00E0ria. El tipus m\u00E9s com\u00FA de c\u00E0ncer de bufeta comen\u00E7a en les c\u00E8l\u00B7lules que recobreixen l'interior (l'uroteli) de la bufeta i es diu . Els principals factors per al desenvolupament del c\u00E0ncer de bufeta inclouen productes qu\u00EDmics espec\u00EDfics, que es troben fonamentalment en el fum dels cigarrets. Als pa\u00EFsos del Tercer M\u00F3n, certes infeccions parasit\u00E0ries. Es distingeixen el c\u00E0ncer superficial de bufeta del c\u00E0ncer invasiu. Si el c\u00E0ncer continua sent superficial, sol cursar amb un bon pron\u00F2stic, mentre que el c\u00E0ncer invasiu de la bufeta \u00E9s molt m\u00E9s greu i requereix tractament agressiu. El tractament del c\u00E0ncer vesical gira en funci\u00F3 de la seva extensi\u00F3, pel m\u00E9s superficial generalment es resol amb resecci\u00F3 de l'uroteli i quimioter\u00E0pia, pel m\u00E9s greu cal la (extirpaci\u00F3 de la bufeta) o la quimioter\u00E0pia sist\u00E8mica."@ca . . . . . "C\u00E2ncer de bexiga (portugu\u00EAs brasileiro) ou cancro da bexiga (portugu\u00EAs europeu) (tamb\u00E9m chamado de Carcinoma Urotelial) \u00E9 um dos v\u00E1rios tipos de c\u00E2ncer, decorrentes de tecidos da bexiga urin\u00E1ria, no qual as c\u00E9lulas da doen\u00E7a crescem de forma anormal e t\u00EAm o potencial de se espalhar para outras partes do corpo. Sintomas incluem sangue na urina, dor ao urinar e dor lombar."@pt . . . . . . "El c\u00E1ncer de vejiga o c\u00E1ncer vesical es un tipo de tumor maligno que aparece en la vejiga urinaria. Los principales factores para el desarrollo del c\u00E1ncer de vejiga incluyen productos qu\u00EDmicos espec\u00EDficos, que se encuentran fundamentalmente en el humo de los cigarrillos. En los pa\u00EDses del Tercer Mundo, ciertas infecciones parasitarias. El tratamiento del c\u00E1ncer vesical gira en funci\u00F3n de la extensi\u00F3n del mismo, generalmente se resuelve con quimioterapia, la remoci\u00F3n de la vejiga o la quimioterapia sist\u00E9mica. Se distinguen el c\u00E1ncer superficial de vejiga del c\u00E1ncer invasivo. Si el c\u00E1ncer sigue siendo superficial, suele cursar con un buen pron\u00F3stico, mientras que el c\u00E1ncer invasivo de la vejiga es mucho m\u00E1s grave y requiere tratamiento agresivo. Cuando la enfermedad se asocia con la amplia p"@es . . . . . . "109800"^^ . . . "\uBC29\uAD11\uC554(\u8180\u80F1\u764C)\uC740 \uBC29\uAD11\uC5D0\uC11C \uBC1C\uC0DD\uD558\uB294 \uC0C1\uD53C \uC545\uC131 \uC885\uC591\uC774\uB2E4. \uC99D\uC0C1\uC73C\uB85C \uD608\uB1E8 \uB4F1\uC774 \uBC1C\uC0DD\uD55C\uB2E4. \uD761\uC5F0\uC774 \uC8FC\uC694 \uC6D0\uC778\uC73C\uB85C \uBCF4\uC778\uB2E4. \uD45C\uC7AC\uC131 \uC885\uC591\uC758 \uCD5C\uC18C\uD55C\uC758 \uCE58\uB8CC\uB294 \uB0B4\uC2DC\uACBD\uC801 \uC644\uC804\uC808\uC81C\uC774\uB2E4. \uADFC\uC721\uCDA9\uC744 \uCCA8\uBC94\uD558\uB294 \uC9C8\uD658\uC758 \uACBD\uC6B0\uB294 \uC6D0\uBC1C\uC554\uC758 \uCE58\uB8CC\uC640 \uBBF8\uC138\uC804\uC774\uC554 \uCE58\uB8CC\uB97C \uC704\uD55C \uC804\uC2E0 \uD56D\uC554\uC694\uBC95\uC73C\uB85C \uB098\uB260 \uC218 \uC788\uB2E4. \uB610\uD55C \uAC15\uC544\uC9C0\uC5D0\uAC8C\uB3C4 \uAC78\uB9AC\uAE30\uAC00 \uC26C\uC6B4 \uCE58\uBA85\uC801\uC778 \uC9C8\uBCD1 \uC911\uC758 \uD558\uB098\uC774\uB2E4. \uAC15\uC544\uC9C0 \uBC29\uAD11\uC554\uB3C4 \uC0C1\uC220\uD55C \uBC14\uC640 \uAC19\uC774 \uAC04\uC811 \uD761\uC5F0, \uC0B4\uCDA9\uC81C, \uC81C\uCD08\uC81C \uB4F1\uB3C4 \uBC29\uAD11\uC554\uC744 \uC77C\uC73C\uD0A4\uB294 \uC774\uC720 \uC5ED\uC2DC \uB420 \uC218\uB3C4 \uC788\uB2E4."@ko .